Kinney Gene G. 4
4 · PROTHENA CORP PUBLIC LTD CO · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Kinney Gene G.
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-03-02+155,000→ 155,000 totalExercise: $52.97Exp: 2033-03-02→ Ordinary Shares (155,000 underlying)
Footnotes (2)
- [F1]The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
- [F2]The Reporting Person holds options that give him the right to acquire an aggregate of 2,159,700 shares at exercise prices ranging from $12.15 to $52.97, of which 1,642,200 are currently exercisable, and 517,500 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award.